Article info
PDFUterine Cancer
A New Diagnostic and Prognostic Marker in Endometrial Cancer: Neopterin
- Address correspondence and reprint requests to Esra Isci Bostanci, MD, The Department of Gynecologic Oncology, Gazi University Medical Faculty Hospital, Besevler, Yenimahalle, Ankara, Turkey 06560. E-mail: dresrai{at}yahoo.com.tr.
Citation
A New Diagnostic and Prognostic Marker in Endometrial Cancer: Neopterin
Publication history
- Received November 9, 2016
- Accepted January 23, 2017
- First published May 1, 2017.
Online issue publication
January 28, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.